Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism.

This study identifies an association between gut microbiota richness, ceramides, and diabetes risk in overweight/obese humans, and suggests that the gut microbiota may contribute to dysregulation of lipid metabolism in metabolic disorders.